For release at 6:30 a.m.
DUSA Pharmaceuticals, Inc.® to Webcast
Annual Meeting of Shareholders
Wilmington, Mass. – June 2, 2011 - DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA) announces that it will host a live audio webcast of its Annual Meeting of Shareholders at 11:00am (Eastern Time) on Wednesday, June 8, 2011.
A replay of the meeting will be available shortly after the live call concludes. To access the replay, visit the Investors section of Company’s website at www.dusapharma.com and click on the Webcast link.
About DUSA Pharmaceuticals
DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan® PDT technology platform, and other dermatology products. Levulan® Kerastick® for topical solution plus DUSA’s BLU-U® blue light photodynamic therapy illuminator is currently approved for the treatment of minimally to moderately thick actinic keratoses (AKs) of the face or scalp. DUSA also markets other dermatology products, including ClindaReach®. DUSA is based in Wilmington, Mass. Please visit our website at www.dusapharma.com.
For further information contact:
Chad Rubin, The Trout Group LLC